3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Thromboembolism
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Polycythemia Vera
1
Neoplasm Metastasis
1
Head and Neck Neoplasms
1
Breast Neoplasms
1
Interventions
fludarabine phosphate
18
Cyclophosphamide
16
Peripheral Blood Stem Cell Transplantation
12
Whole-Body Irradiation
11
Busulfan
11
Tacrolimus
10
Mycophenolic Acid
10
ruxolitinib
9
fludarabine
7
Methotrexate
6
Cyclosporine
6
Radiotherapy
5
Aspirin
5
Prednisone
4
Melphalan
4
Imatinib Mesylate
4
Biopsy
4
Antilymphocyte Serum
4
peginterferon alfa-2a
3
givinostat hydrochloride
3
givinostat
3
Stem Cell Transplantation
3
Specimen Handling
3
Decitabine
3
bomedemstat
2
Thiotepa
2
Surveys and Questionnaires
2
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
2
Methylprednisolone
2
Lenalidomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Polycythemia Vera
×
Clopidogrel
×
Clear all
NCT00940784
2014-11-26
ISCLAP
Icahn School of Medicine at Mount Sinai
Phase 2
Withdrawn